COVID-19 is the disease cause by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).[@bib1] The World Health Organisation (WHO) declared COVID-19 a global pandemic on 11 March 2020.[@bib2] Radiographers, patient facing, frontline health professionals, have a key role in the diagnosis and management of COVID-19. Diagnosis of SARS-CoV-2 is confirmed by reverse transcription polymerase chain reaction (RT-PCR) of nasopharyngeal swabs.[@bib3] However, sensitivity is variable reported to be 70%--90% on initial swab[@bib4] and 90% on second swab at 72 h.[@bib5]

The British Society of Thoracic Imaging (BSTI) have developed a clinical decision support tool to aid clinicians, radiographers and radiologists when managing patients where COVID-19 is within the differential diagnosis -- the chest radiograph (CXR) forms the bedrock of this tool.[@bib6] CXRs are a key diagnostic test when investigating patients with respiratory symptoms and are advocated as the first imaging examination in patients with suspected COVID-19. Mobile CXRs are an important diagnostic test in the evaluation of critically unwell patients, and in particular will have a role in minimising the transmission risk of SARS-CoV-2 associated with patient transfer. Baseline CXRs have a reported sensitivity of 69% compared to baseline RT-PCR thus far, but analysis has been lacking due to puzzlingly limited use of CXR in the outbreak to date.[@bib4]

Preliminary clinical evaluation (PCE) by radiographers at time of image acquisition is an expected competency of practitioners in many regions including the United Kingdom[@bib7] and Australia.[@bib8] As radiographers are almost invariably the first practitioner to see the diagnostic image, it follows that radiographer PCE and triage for an immediate clinical report plays a vital role in identifying possible COVID-19 patients. There are increasing case reports of patients presenting to hospital without classical symptoms of COVID-19 (fever, cough), including abdominal symptoms,[@bib9] ^,^ [@bib10] and may be referred for non-COVID diagnostic workup without respiratory precautions in place. Rapid radiographer PCE and triage will facilitate prompt reporting of the investigation, aid patient diagnosis and management decisions in a timely way. This rapid triage also allows for the potential of all imaging to be performed during a single hospital attendance and, more crucially, immediate appropriate decontamination of imaging equipment.

It is crucial that radiographers, radiologists and referring clinicians are aware that a normal imaging investigation (CXR or CT) does not exclude COVID-19 in high risk patients.[@bib4] Thus, a 'completion' chest CT to identify COVID-19 when the lung bases are normal on a routine CT abdomen in a patient who has no COVID-19 respiratory symptoms is not advocated. Also, personal protective equipment (PPE) and infection control precautions should continue, based on clinical suspicion. When imaging is abnormal, findings are frequently non-specific and need to be incorporated with the relevant clinical symptoms and findings on blood tests (most notably elevated C-reactive protein (CRP) and lymphopenia \<1100 μ/L).[@bib6]

This case report series presents a summary of key findings frequently associated with COVID-19 and will assist radiographer PCE. Chest imaging features associated with COVID-19 (ref BSTI reporting template) are presented in [Table 1](#tbl1){ref-type="table"} .[@bib11] Table 1Chest imaging features associated with COVID-19.[@bib11]Table 1COVID-19Imaging FeaturesClassic/Probable (\>70% confidence)•Bilateral•Lower zone predominance•Ground-glass•PeripheralIndeterminate (\<70% confidence)Does not fit into definite or probable or Non-COVID.Normal•Does not exclude COVID-19 entirely. If the patient has clinical symptoms of COVID-19 RT-PCR should be considered.Non-COVID•Lobar pneumonia•Pleural effusion

A 69-year-old female presented to the emergency department with a three-day history of fever (temperature 38.2 C) and shortness of breath (oxygen saturation 87%), normal white cell count (6400 μ/L) but lymphopenia (890 μ/L) and an elevated CRP (149, normal \<5). Mobile chest radiograph ([Fig. 1](#fig1){ref-type="fig"} ) demonstrates classical findings associated with COVID-19 of bilateral, predominantly peripheral lower zone ground glass and interstitial opacification. Nasopharyngeal swab RT-PCR was positive for SARS-CoV-2.Figure 1Index chest radiograph of a 69 year old female with bilateral, peripheral ground glass and interstitial opacification (Classic/Probable COVID-19).Figure 1

A 93-year-old female presented to the emergency department with a 10-day history of shortness of breath (oxygen saturation 66%), elevated CRP (71), normal white cell count (9500 μ/L) and lymphopenia (930 μ/L). Index (Day 0, [Fig. 2](#fig2){ref-type="fig"} a) chest radiograph appearances were indeterminate with bilateral mid and lower zone interstitial opacification. Rapid progression occurred across seven days, with bilateral ground glass opacification ([Fig. 2](#fig2){ref-type="fig"}b) and development of acute respiratory distress syndrome ([Fig. 2](#fig2){ref-type="fig"}c). Nasopharyngeal swab RT-PCR was positive for SARS-CoV-2.Figure 2a. Index chest radiograph (Day 0) with unilateral lower zone interstitial opacification (Indeterminate COVID-19). b. Repeat chest radiograph day 5 with bilateral ground glass opacification in the lower zones (Classic/Probable COVID-19). c. Repeat chest radiograph day 7 with diffuse bilateral ground glass opacification (Classic/Probable COVID).Figure 2

A 72-year-old male presented to the emergency department with a three-day history of right flank pain without dysuria and microscopic haematuria, temperature 37.1 C, oxygen saturation 98%, mildly elevated CRP,[@bib11] normal white cell count (4600 μ/L) and lymphocytes (1200 μ/L). A low dose CT abdomen was performed to investigate possible renal calculi. CT was negative for renal calculi however demonstrated subtle ground glass opacification of the left lower lobe ([Fig. 3](#fig3){ref-type="fig"} a). CT chest was performed with peripheral ground glass opacification in the right upper lobe ([Fig. 3](#fig3){ref-type="fig"}b). Nasopharyngeal swab was not sent but the patient was given a clinical diagnosis of COVID-19.Figure 3a. CT abdomen with left lower lobe ground glass opacification (Indeterminate COVID-19). b. CT chest with right upper lobe peripheral ground glass opacification (Indeterminate COVID-19). Clinico-radiological diagnosis of COVID-19, swab not sent.Figure 3
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